Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer

PURPOSE: To determine the effects of bevacizumab on patient-reported outcomes (PROs; secondary end point) in the AURELIA trial. PATIENTS AND METHODS: Patients with platinum-resistant ovarian cancer were randomly assigned to chemotherapy alone (CT) or with bevacizumab (BEV-CT). PROs were assessed usi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Stockler, Martin R., Hilpert, Felix, Friedlander, Michael, King, Madeleine T., Wenzel, Lari, Lee, Chee Khoon, Joly, Florence, de Gregorio, Nikolaus, Arranz, José Angel, Mirza, Mansoor Raza, Sorio, Roberto, Freudensprung, Ulrich, Sneller, Vesna, Hales, Gill, Pujade-Lauraine, Eric
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2014
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876313/
https://ncbi.nlm.nih.gov/pubmed/24687829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.51.4240
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker